UniProt ID | PLXA1_HUMAN | |
---|---|---|
UniProt AC | Q9UIW2 | |
Protein Name | Plexin-A1 | |
Gene Name | PLXNA1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1896 | |
Subcellular Localization |
Cell membrane Single-pass type I membrane protein. |
|
Protein Description | Coreceptor for SEMA3A, SEMA3C, SEMA3F and SEMA6D. Necessary for signaling by class 3 semaphorins and subsequent remodeling of the cytoskeleton. Plays a role in axon guidance, invasive growth and cell migration. Class 3 semaphorins bind to a complex composed of a neuropilin and a plexin. The plexin modulates the affinity of the complex for specific semaphorins, and its cytoplasmic domain is required for the activation of down-stream signaling events in the cytoplasm (By similarity).. | |
Protein Sequence | MPLPPRSLQVLLLLLLLLLLLPGMWAEAGLPRAGGGSQPPFRTFSASDWGLTHLVVHEQTGEVYVGAVNRIYKLSGNLTLLRAHVTGPVEDNEKCYPPPSVQSCPHGLGSTDNVNKLLLLDYAANRLLACGSASQGICQFLRLDDLFKLGEPHHRKEHYLSSVQEAGSMAGVLIAGPPGQGQAKLFVGTPIDGKSEYFPTLSSRRLMANEEDADMFGFVYQDEFVSSQLKIPSDTLSKFPAFDIYYVYSFRSEQFVYYLTLQLDTQLTSPDAAGEHFFTSKIVRLCVDDPKFYSYVEFPIGCEQAGVEYRLVQDAYLSRPGRALAHQLGLAEDEDVLFTVFAQGQKNRVKPPKESALCLFTLRAIKEKIKERIQSCYRGEGKLSLPWLLNKELGCINSPLQIDDDFCGQDFNQPLGGTVTIEGTPLFVDKDDGLTAVAAYDYRGRTVVFAGTRSGRIRKILVDLSNPGGRPALAYESVVAQEGSPILRDLVLSPNHQYLYAMTEKQVTRVPVESCVQYTSCELCLGSRDPHCGWCVLHSICSRRDACERADEPQRFAADLLQCVQLTVQPRNVSVTMSQVPLVLQAWNVPDLSAGVNCSFEDFTESESVLEDGRIHCRSPSAREVAPITRGQGDQRVVKLYLKSKETGKKFASVDFVFYNCSVHQSCLSCVNGSFPCHWCKYRHVCTHNVADCAFLEGRVNVSEDCPQILPSTQIYVPVGVVKPITLAARNLPQPQSGQRGYECLFHIPGSPARVTALRFNSSSLQCQNSSYSYEGNDVSDLPVNLSVVWNGNFVIDNPQNIQAHLYKCPALRESCGLCLKADPRFECGWCVAERRCSLRHHCAADTPASWMHARHGSSRCTDPKILKLSPETGPRQGGTRLTITGENLGLRFEDVRLGVRVGKVLCSPVESEYISAEQIVCEIGDASSVRAHDALVEVCVRDCSPHYRALSPKRFTFVTPTFYRVSPSRGPLSGGTWIGIEGSHLNAGSDVAVSVGGRPCSFSWRNSREIRCLTPPGQSPGSAPIIININRAQLTNPEVKYNYTEDPTILRIDPEWSINSGGTLLTVTGTNLATVREPRIRAKYGGIERENGCLVYNDTTMVCRAPSVANPVRSPPELGERPDELGFVMDNVRSLLVLNSTSFLYYPDPVLEPLSPTGLLELKPSSPLILKGRNLLPPAPGNSRLNYTVLIGSTPCTLTVSETQLLCEAPNLTGQHKVTVRAGGFEFSPGTLQVYSDSLLTLPAIVGIGGGGGLLLLVIVAVLIAYKRKSRDADRTLKRLQLQMDNLESRVALECKEAFAELQTDIHELTNDLDGAGIPFLDYRTYAMRVLFPGIEDHPVLKEMEVQANVEKSLTLFGQLLTKKHFLLTFIRTLEAQRSFSMRDRGNVASLIMTALQGEMEYATGVLKQLLSDLIEKNLESKNHPKLLLRRTESVAEKMLTNWFTFLLYKFLKECAGEPLFMLYCAIKQQMEKGPIDAITGEARYSLSEDKLIRQQIDYKTLTLNCVNPENENAPEVPVKGLDCDTVTQAKEKLLDAAYKGVPYSQRPKAADMDLEWRQGRMARIILQDEDVTTKIDNDWKRLNTLAHYQVTDGSSVALVPKQTSAYNISNSSTFTKSLSRYESMLRTASSPDSLRSRTPMITPDLESGTKLWHLVKNHDHLDQREGDRGSKMVSEIYLTRLLATKGTLQKFVDDLFETIFSTAHRGSALPLAIKYMFDFLDEQADKHQIHDADVRHTWKSNCLPLRFWVNVIKNPQFVFDIHKNSITDACLSVVAQTFMDSCSTSEHKLGKDSPSNKLLYAKDIPNYKSWVERYYADIAKMPAISDQDMSAYLAEQSRLHLSQFNSMSALHEIYSYITKYKDEILAALEKDEQARRQRLRSKLEQVVDTMALSS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
77 | N-linked_Glycosylation | RIYKLSGNLTLLRAH HEEEECCCEEEEEEE | 26.86 | 19349973 | |
159 | Phosphorylation | PHHRKEHYLSSVQEA CCCCCHHHHHHHHHH | 14.90 | 22210691 | |
161 | Phosphorylation | HRKEHYLSSVQEAGS CCCHHHHHHHHHHHC | 22.69 | 22210691 | |
168 | Phosphorylation | SSVQEAGSMAGVLIA HHHHHHHCCCCEEEE | 16.71 | 22210691 | |
194 | Ubiquitination | VGTPIDGKSEYFPTL EECCCCCCCCCCCCH | 36.04 | - | |
361 | Phosphorylation | ESALCLFTLRAIKEK HHHHHHHHHHHHHHH | 11.46 | 24719451 | |
375 | Phosphorylation | KIKERIQSCYRGEGK HHHHHHHHHHCCCCC | 15.67 | 27794612 | |
377 | Phosphorylation | KERIQSCYRGEGKLS HHHHHHHHCCCCCCC | 27.22 | 27794612 | |
382 | Ubiquitination | SCYRGEGKLSLPWLL HHHCCCCCCCHHHHH | 30.51 | - | |
629 | Phosphorylation | AREVAPITRGQGDQR HHHCCCCCCCCCCHH | 27.91 | 22210691 | |
660 | N-linked_Glycosylation | SVDFVFYNCSVHQSC ECEEEEEECCCCHHH | 10.50 | UniProtKB CARBOHYD | |
672 | N-linked_Glycosylation | QSCLSCVNGSFPCHW HHHHHHHCCCCCCCH | 44.72 | UniProtKB CARBOHYD | |
701 | N-linked_Glycosylation | AFLEGRVNVSEDCPQ HHHCCCCCCCCCCCC | 30.18 | UniProtKB CARBOHYD | |
726 | O-linked_Glycosylation | VGVVKPITLAARNLP CEEEECEEEHHCCCC | 20.90 | 55828069 | |
751 | Phosphorylation | CLFHIPGSPARVTAL EEEECCCCCCEEEEE | 15.27 | 26699800 | |
816 | S-palmitoylation | CPALRESCGLCLKAD CHHHHHHCCEECCCC | 4.06 | 29575903 | |
819 | S-palmitoylation | LRESCGLCLKADPRF HHHHCCEECCCCCCC | 1.91 | 29575903 | |
952 | Phosphorylation | SPHYRALSPKRFTFV CCCCHHCCCCCEEEE | 27.65 | 24719451 | |
1041 | Ubiquitination | QLTNPEVKYNYTEDP HCCCCCCCCCCCCCC | 26.56 | 22817900 | |
1043 | N-linked_Glycosylation | TNPEVKYNYTEDPTI CCCCCCCCCCCCCCE | 31.37 | 19349973 | |
1059 | Ubiquitination | RIDPEWSINSGGTLL EECCCCEECCCCEEE | 5.08 | 22817900 | |
1097 | Phosphorylation | RENGCLVYNDTTMVC EECCEEEEECCEEEE | 8.38 | - | |
1167 | Phosphorylation | LLELKPSSPLILKGR CEEECCCCCEEEECC | 32.05 | 26437602 | |
1187 | N-linked_Glycosylation | APGNSRLNYTVLIGS CCCCCCCEEEEEECC | 29.35 | UniProtKB CARBOHYD | |
1195 | O-linked_Glycosylation | YTVLIGSTPCTLTVS EEEEECCCCCEEEEE | 19.71 | OGP | |
1212 | N-linked_Glycosylation | QLLCEAPNLTGQHKV EEEEECCCCCCCCEE | 58.23 | UniProtKB CARBOHYD | |
1353 | Ubiquitination | EVQANVEKSLTLFGQ EECCHHHHHHHHHHH | 46.62 | - | |
1380 | Phosphorylation | RTLEAQRSFSMRDRG HHHHHHHCCCCCCCC | 15.03 | 28165663 | |
1382 | Phosphorylation | LEAQRSFSMRDRGNV HHHHHCCCCCCCCHH | 17.72 | 28165663 | |
1391 | Phosphorylation | RDRGNVASLIMTALQ CCCCHHHHHHHHHHH | 17.72 | 28165663 | |
1403 | Phosphorylation | ALQGEMEYATGVLKQ HHHHHHHHHHHHHHH | 14.25 | - | |
1418 | Ubiquitination | LLSDLIEKNLESKNH HHHHHHHHHHHCCCC | 60.89 | 23000965 | |
1422 | Phosphorylation | LIEKNLESKNHPKLL HHHHHHHCCCCHHHH | 41.76 | 20886841 | |
1423 | Ubiquitination | IEKNLESKNHPKLLL HHHHHHCCCCHHHHH | 50.31 | 23000965 | |
1427 | Ubiquitination | LESKNHPKLLLRRTE HHCCCCHHHHHHCCH | 44.19 | - | |
1436 | Ubiquitination | LLRRTESVAEKMLTN HHHCCHHHHHHHHHH | 6.93 | 21890473 | |
1441 | Ubiquitination | ESVAEKMLTNWFTFL HHHHHHHHHHHHHHH | 5.05 | 23000965 | |
1454 | Acetylation | FLLYKFLKECAGEPL HHHHHHHHHHCCCCH | 54.61 | 19827757 | |
1486 | Phosphorylation | AITGEARYSLSEDKL CCCCCEECCCCHHHH | 22.47 | 28102081 | |
1487 | Phosphorylation | ITGEARYSLSEDKLI CCCCEECCCCHHHHH | 21.62 | 28102081 | |
1492 | Ubiquitination | RYSLSEDKLIRQQID ECCCCHHHHHHHHCC | 41.59 | - | |
1500 | Phosphorylation | LIRQQIDYKTLTLNC HHHHHCCCCEEEEEC | 13.91 | - | |
1501 | Ubiquitination | IRQQIDYKTLTLNCV HHHHCCCCEEEEECC | 33.05 | 29967540 | |
1521 | Ubiquitination | NAPEVPVKGLDCDTV CCCCCCCCCCCCHHH | 47.92 | 29967540 | |
1574 | Phosphorylation | ILQDEDVTTKIDNDW EECCCCCCCCCCCCH | 34.39 | 25332170 | |
1575 | Phosphorylation | LQDEDVTTKIDNDWK ECCCCCCCCCCCCHH | 26.33 | 25332170 | |
1576 | Ubiquitination | QDEDVTTKIDNDWKR CCCCCCCCCCCCHHH | 38.40 | 29967540 | |
1590 | Phosphorylation | RLNTLAHYQVTDGSS HHHCCEEEEECCCCC | 10.08 | 27642862 | |
1597 | Phosphorylation | YQVTDGSSVALVPKQ EEECCCCCEEEEECC | 19.55 | - | |
1605 | Phosphorylation | VALVPKQTSAYNISN EEEEECCCCCCCCCC | 22.81 | 21945579 | |
1606 | Phosphorylation | ALVPKQTSAYNISNS EEEECCCCCCCCCCC | 26.68 | 21945579 | |
1608 | Phosphorylation | VPKQTSAYNISNSST EECCCCCCCCCCCHH | 16.88 | 21945579 | |
1611 | Phosphorylation | QTSAYNISNSSTFTK CCCCCCCCCCHHHHH | 27.33 | 21945579 | |
1613 | Phosphorylation | SAYNISNSSTFTKSL CCCCCCCCHHHHHHH | 24.78 | 21945579 | |
1614 | Phosphorylation | AYNISNSSTFTKSLS CCCCCCCHHHHHHHH | 31.61 | 21945579 | |
1615 | Phosphorylation | YNISNSSTFTKSLSR CCCCCCHHHHHHHHH | 34.83 | 25849741 | |
1617 | Phosphorylation | ISNSSTFTKSLSRYE CCCCHHHHHHHHHHH | 21.58 | 21945579 | |
1618 | Ubiquitination | SNSSTFTKSLSRYES CCCHHHHHHHHHHHH | 45.25 | 23000965 | |
1619 | Phosphorylation | NSSTFTKSLSRYESM CCHHHHHHHHHHHHH | 28.64 | 28796482 | |
1621 | Phosphorylation | STFTKSLSRYESMLR HHHHHHHHHHHHHHH | 39.65 | 28796482 | |
1623 | Phosphorylation | FTKSLSRYESMLRTA HHHHHHHHHHHHHHC | 14.69 | 28796482 | |
1625 | Phosphorylation | KSLSRYESMLRTASS HHHHHHHHHHHHCCC | 17.74 | 28796482 | |
1629 | Phosphorylation | RYESMLRTASSPDSL HHHHHHHHCCCCHHH | 27.25 | 29396449 | |
1631 | Phosphorylation | ESMLRTASSPDSLRS HHHHHHCCCCHHHHC | 41.62 | 28176443 | |
1632 | Phosphorylation | SMLRTASSPDSLRSR HHHHHCCCCHHHHCC | 30.20 | 25159151 | |
1635 | Phosphorylation | RTASSPDSLRSRTPM HHCCCCHHHHCCCCC | 29.12 | 25159151 | |
1636 | Ubiquitination | TASSPDSLRSRTPMI HCCCCHHHHCCCCCC | 8.21 | 23000965 | |
1638 | Phosphorylation | SSPDSLRSRTPMITP CCCHHHHCCCCCCCC | 45.88 | 30576142 | |
1642 | Sulfoxidation | SLRSRTPMITPDLES HHHCCCCCCCCCCHH | 5.43 | 21406390 | |
1651 | Phosphorylation | TPDLESGTKLWHLVK CCCCHHCCCHHHHHH | 32.04 | 22210691 | |
1672 | Phosphorylation | QREGDRGSKMVSEIY HCCCCHHHHHHHHHH | 20.62 | 24719451 | |
1679 | Phosphorylation | SKMVSEIYLTRLLAT HHHHHHHHHHHHHCC | 9.66 | - | |
1687 | Ubiquitination | LTRLLATKGTLQKFV HHHHHCCHHHHHHHH | 44.27 | 29967540 | |
1769 | Phosphorylation | DIHKNSITDACLSVV EECCCCHHHHHHHHH | 19.84 | 29116813 | |
1793 | Ubiquitination | TSEHKLGKDSPSNKL CCCCCCCCCCCCCCE | 66.52 | 29967540 | |
1797 | Phosphorylation | KLGKDSPSNKLLYAK CCCCCCCCCCEEEEC | 51.02 | 28857561 | |
1799 | Ubiquitination | GKDSPSNKLLYAKDI CCCCCCCCEEEECCC | 44.18 | 29967540 | |
1804 | Ubiquitination | SNKLLYAKDIPNYKS CCCEEEECCCCCHHH | 42.51 | 29967540 | |
1817 | Phosphorylation | KSWVERYYADIAKMP HHHHHHHHHHHHCCC | 12.20 | - | |
1863 | Ubiquitination | YSYITKYKDEILAAL HHHHHHCHHHHHHHH | 50.90 | 29967540 | |
1872 | Ubiquitination | EILAALEKDEQARRQ HHHHHHHHHHHHHHH | 68.37 | 29967540 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PLXA1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PLXA1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
AKT1_HUMAN | AKT1 | physical | 15187088 | |
PLXA1_HUMAN | PLXNA1 | physical | 15187088 | |
PLXA1_HUMAN | PLXNA1 | physical | 11239433 | |
NRP1_HUMAN | NRP1 | physical | 11239433 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins."; Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,Schiess R., Aebersold R., Watts J.D.; Nat. Biotechnol. 27:378-386(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-77 AND ASN-1043, AND MASSSPECTROMETRY. |